Projects (90)

Yes/No shellfish toxin test Sep 1, 2023 - Mar 31, 2024
The UK shellfish industry uses qualitative tests for management of range of toxins in shellfish products. The only supplier of these tests, Neogen will discontinue these tests by the end of 2023. CyanSol group and partners are dedicated to developin... Read More about Yes/No shellfish toxin test.

Exploring the anti-atherogenic properties of a compound derived from Amaryllidaceae (Daffodil) Sep 1, 2023 - Apr 30, 2024
Agroceutical Products Ltd (APL) produces sustainable quantities of the naturally derived alkaloid galanthamine from daffodils, which is a key active pharmaceutical used for the treatment of Alzheimer’s disease. Daffodils contain an abundance of other... Read More about Exploring the anti-atherogenic properties of a compound derived from Amaryllidaceae (Daffodil).

Development of a pre-rehabilitation program informed by cognitive behavioural therapy (pR-CBT) to improve outcomes in total knee arthroplasty (TKA) Apr 1, 2022 - Jul 31, 2024
Total knee arthroplasty (TKA) is one of the most common and effective treatments for severe knee osteoarthritis, with >100,000 knee replacements performed in the UK annually. Despite success in reduction of pain after knee replacements, around 1 in 5... Read More about Development of a pre-rehabilitation program informed by cognitive behavioural therapy (pR-CBT) to improve outcomes in total knee arthroplasty (TKA).

Health Determinants Research Collaborative Oct 1, 2022 - Sep 30, 2027
A Health Determinants Research Collaborative in Aberdeen will bring unique opportunities for the City, its residents and as a path-finder for UK-wide and international learning. Our proposal is based on i) the strength of our existing arrangements f... Read More about Health Determinants Research Collaborative.

Development and characterisation of novel polymer-drug conjugates for the treatment of Alzheimer’s disease Sep 1, 2022 - Aug 31, 2024
Using new polymer-drug compounds to improve the ability to deliver anti-Alzheimer drugs in the body.

 A feminist mixed-methods exploration of UK midwives’ attitudes and experiences on freebirth Oct 1, 2020 - Mar 31, 2027
Freebirth is the term used to describe a birth that happens intentionally without the attendance of a qualified health care professional, even when free, universal access to midwifery care is provided by public health care services. The last decade h... Read More about  A feminist mixed-methods exploration of UK midwives’ attitudes and experiences on freebirth.

Resilience and responses to interconnecting crises in informal settings (ISPF) Apr 1, 2024 - Mar 31, 2025
Over 1 billion people – including close to 500 million children – live in so-called slums and informal settlements, mostly in cities in Africa, Asia and Latin America. Residents in poor urban informal neighbourhoods face many challenges and everyday... Read More about Resilience and responses to interconnecting crises in informal settings (ISPF).

Urban Observatory for Multi-participatory Enhancement of Health and Wellbeing Mar 1, 2021 - Feb 28, 2025
Our natural and built environment and social fabric are critical determinants of health and well-being. Three quarters of the European population now live in cities and urbanisation continues at high speed, driven by economic growth and employment op... Read More about Urban Observatory for Multi-participatory Enhancement of Health and Wellbeing.

A comparative study of associations between time to first antenatal appointment and preterm births in rural Georgia and rural Scotland Jul 1, 2022 - Nov 30, 2023
A study to compare the prevalence of preterm births between rural Georgia and rural Scotland followed by a comparative analysis of the two health systems.

Impact of long COVID on critical workers Nov 1, 2023 - Apr 30, 2025
This project aims to understand the impact of long COVID on critical services (NHS, Education and Police). Including understanding the scale of the problem, the experiences of staff at work (or not) with LC and colleagues, and the experiences of thos... Read More about Impact of long COVID on critical workers.

Understanding barriers to care through the perspectives of new mothers who experienced delayed antenatal care in rural Georgia and rural Scotland Apr 1, 2023 - Nov 30, 2024
Delayed access to antenatal care or late booking has been associated with increased maternal and infant mortality and morbidity. Studies have consistently indicated antenatal care plays a vital role in the prevention of preterm births. Preliminary... Read More about Understanding barriers to care through the perspectives of new mothers who experienced delayed antenatal care in rural Georgia and rural Scotland.

Exploration of family carers' experiences of support for rapid discharge arrangements for end of life care at home Jul 1, 2020 - Jun 30, 2023
Many patients and their families would prefer home-based end of life care, however, without appropriate support this can be a frightening experience. We aim to explore family carers experiences of support in preparation for rapid discharge for end of... Read More about Exploration of family carers' experiences of support for rapid discharge arrangements for end of life care at home.

Perceptions of an educational approach to transformative and sustainable practice for health and social care practitioners Apr 1, 2023 - Sep 30, 2024
RGUs accredited course for support workers is the Diploma of Higher Education Wellbeing and Enablement which was developed in partnership with NHS Grampian and aims to shape the thinking and practice of support workers as frontline providers of healt... Read More about Perceptions of an educational approach to transformative and sustainable practice for health and social care practitioners.

One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines Oct 1, 2023 - Sep 30, 2027
There is a need to reduce pollutants at source instead of relying on water treatment for their removal. The One Health Breakthrough Partnership is working to reduce pharmaceutical pollution entering the environment. This includes prescribing medicine... Read More about One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines.

One Health Medicine – developing a predictive tool for pharmaceuticals in wastewater Oct 30, 2023 - Nov 1, 2024
Medicines are used everyday by humans. However, they can be detrimental to aquatic life. Pharmaceuticals enter the environment following human excretion and transport through wastewater systems. The danger pharmaceuticals pose is location specific de... Read More about One Health Medicine – developing a predictive tool for pharmaceuticals in wastewater.

Valorisation of Biomass from the Daffodil Growing Industry Oct 1, 2021 - Sep 30, 2025
The UK is a world leader in the commercial production of daffodils, with Scottish-based farmers’ cooperative Grampian Growers Ltd (GG) at the forefront of the industry. The majority of daffodil biomass produced by GG is used for bulb and flower expo... Read More about Valorisation of Biomass from the Daffodil Growing Industry.

Bioactivity of a compound derived from Amaryllidaceae (Daffodil) in a C.elegans model of obesity Sep 1, 2023 - May 30, 2024
A previous proof-of-concept study demonstrated that an alkaloid extracted from daffodil bulbs by Agroceutical Products Ltd (APL), alongside sustainable galanthamine production (alkaloid used for Alzheimer’s disease management), selectively reduced re... Read More about Bioactivity of a compound derived from Amaryllidaceae (Daffodil) in a C.elegans model of obesity.

Cannabidiol and CBD oil for prevention of cardiac dysfunction Mar 9, 2023 - Dec 19, 2024
Cannabidiol (CBD) has cardioprotective properties against the outcome of myocardial ischaemia and reperfusion. CBD oil, which contains not only cannabidiol but a host of biologically active molecules that may also offer some benefits to cardiac heal... Read More about Cannabidiol and CBD oil for prevention of cardiac dysfunction.

The role of Glutathione Peroxidase 4 (GPX4) and the GPX4 single-nucleotide polymorphism (SNP), rs713041, in metabolic syndrome associated vascular dysfunction Sep 1, 2023 - Apr 30, 2025
High blood sugar, high blood pressure, and obesity are all features of the ‘umbrella term’ metabolic syndrome (MetS) which affects 1 in 3 people over 50 years old in the UK. MetS increases the risk of developing heart disease and in particular the co... Read More about The role of Glutathione Peroxidase 4 (GPX4) and the GPX4 single-nucleotide polymorphism (SNP), rs713041, in metabolic syndrome associated vascular dysfunction.

How do fresh whole blood and blood component therapies containing additive solutions alter the structure and stability of a blood clot during traumatic bleeding? Dec 1, 2023 - Nov 30, 2024
In a military setting, bleeding is the primary cause of preventable death in patients suffering from polytrauma and massive haemorrhage. Access to hospital care and blood products is limited by location, logistics and personnel. Pre-hospital blood in... Read More about How do fresh whole blood and blood component therapies containing additive solutions alter the structure and stability of a blood clot during traumatic bleeding?.